Samsara BioCapital
Palo Alto, United States · Seed → Series B
Their stated focus (public profile)
Samsara BioCapital is a venture capital firm focused exclusively on investing in innovative therapeutic companies, particularly in biotechnology and biopharma. The firm backs transformative therapeutics across a broad range of disease areas including oncology, immunology, neurology, gene therapy, ophthalmology, and rare/orphan diseases. They partner with scientists, physicians, drug developers, and business leaders to support the next generation of therapeutic breakthroughs.
Stages: Seed → Series B
Sectors: Life sciences, Orphan, Cardiometabolic, Gastrointestinal, Renal, Tools, Medtech, Healthtech, Proteomics
On file: 33 companies on record
Website: samsaracap.com
This perch was compiled from public sources — filings, the fund’s own site, public write-ups. None of it is the fund’s own words.
Is this your fund? Request a correction or removal.
Search the funds we have on file
Looking for investors? Search the funds we have on file — what they back, where they are, and whether your raise fits. Sign in and Percy matches you to the right ones.
Looking to claim your own fund? Start here →
This perch was compiled from public sources — filings, the fund’s own site, public write-ups. None of it is the fund’s own words.
Funds closest to this thesis
Ordered by how close each thesis sits to this one.
Is this your fund? Request a correction or removal.